Zobrazeno 1 - 10
of 21
pro vyhledávání: '"Tracey, Remmington"'
Publikováno v:
Cochrane Database Syst Rev
The Cochrane Library
The Cochrane Library
Background Enteral tube feeding is routinely used in many cystic fibrosis centres when oral dietary and supplement intake has failed to achieve an adequate nutritional status. The use of this method of feeding is assessed on an individual basis takin
Enzyme replacement therapy with laronidase (Aldurazyme(®)) for treating mucopolysaccharidosis type I
Publikováno v:
Cochrane Database Syst Rev
BACKGROUND: Mucopolysaccharidosis type I can be classified as three clinical sub‐types; Hurler syndrome, Hurler‐Scheie syndrome and Scheie syndrome, with the scale of severity being such that Hurler syndrome is the most severe and Scheie syndrome
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ccb3bc73174e6b9575f1bf2736eab5ce
https://europepmc.org/articles/PMC6581069/
https://europepmc.org/articles/PMC6581069/
Publikováno v:
Paediatric Respiratory Reviews. 24:32-34
Autor:
Tracey Remmington, Shirley Owusu-Ofori
Publikováno v:
The Cochrane Library
Background Acute splenic sequestration crises are a complication of sickle cell disease, with high mortality rates and frequent recurrence in survivors of first attacks. Splenectomy and blood transfusion, with their consequences, are the mainstay of
Publikováno v:
The Cochrane Library
Background Mucopolysaccharidosis type I can be classified as three clinical sub-types; Hurler syndrome, Hurler-Scheie syndrome and Scheie syndrome, with the scale of severity being such that Hurler syndrome is the most severe and Scheie syndrome the
Publikováno v:
The Cochrane Library
Publikováno v:
Journal of Evidence-Based Medicine. 6:229-231
The Cochrane Cystic Fibrosis and Genetic Disorders Group publishes systematic reviews of randomized trials for many genetic disorders. Given the rarity of these disorders, there are often few relevant trials to be included. Therefore, it is common fo
Publikováno v:
The Cochrane Library
Background Pseudomonas aeruginosa is the most common bacterial pathogen causing lung infections in people with cystic fibrosis and appropriate antibiotic therapy is vital. Antibiotics for pulmonary exacerbations are usually given intravenously, and f
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::52478cd62e1c9e0e7f5952568841475d
https://doi.org/10.1002/14651858.cd005405.pub3
https://doi.org/10.1002/14651858.cd005405.pub3
Publikováno v:
Journal of evidence-based medicine. 6(4)
The Cochrane Cystic Fibrosis and Genetic Disorders Group publishes systematic reviews of randomized trials for many genetic disorders. Given the rarity of these disorders, there are often few relevant trials to be included. Therefore, it is common fo
Publikováno v:
Paediatric respiratory reviews. 14(3)
The Cochrane Collaboration is widely recognised as setting the gold standard for assessing and reporting research to determine the effectiveness of different healthcare treatments and interventions. It is a not-for-profit, global network of approxima